A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
This report aims to provide a comprehensive presentation of the global market for Infectious Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Vaccines. This report contains market size and forecasts of Infectious Vaccines in global, including the following market information:
Global Infectious Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Infectious Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Infectious Vaccines companies in 2022 (%)
The global Infectious Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
We surveyed the Infectious Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Type, 2022 (%)
Preventive Vaccine
Therapeutic Vaccine
Global Infectious Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, by Application, 2022 (%)
Adults
Pediatrics
Global Infectious Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Infectious Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Infectious Vaccines revenues share in global market, 2022 (%)
Key companies Infectious Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Infectious Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Vaccines, market overview.
Chapter 2: Global Infectious Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Infectious Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Infectious Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Vaccines Overall Market Size
2.1 Global Infectious Vaccines Market Size: 2022 VS 2029
2.2 Global Infectious Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Infectious Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Infectious Vaccines Players in Global Market
3.2 Top Global Infectious Vaccines Companies Ranked by Revenue
3.3 Global Infectious Vaccines Revenue by Companies
3.4 Global Infectious Vaccines Sales by Companies
3.5 Global Infectious Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Infectious Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Infectious Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Infectious Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Vaccines Market Size Markets, 2022 & 2029
4.1.2 Preventive Vaccine
4.1.3 Therapeutic Vaccine
4.2 By Type - Global Infectious Vaccines Revenue & Forecasts
4.2.1 By Type - Global Infectious Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Infectious Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Infectious Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Infectious Vaccines Sales & Forecasts
4.3.1 By Type - Global Infectious Vaccines Sales, 2018-2023
4.3.2 By Type - Global Infectious Vaccines Sales, 2024-2029
4.3.3 By Type - Global Infectious Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Vaccines Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Pediatrics
5.2 By Application - Global Infectious Vaccines Revenue & Forecasts
5.2.1 By Application - Global Infectious Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Infectious Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Infectious Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Infectious Vaccines Sales & Forecasts
5.3.1 By Application - Global Infectious Vaccines Sales, 2018-2023
5.3.2 By Application - Global Infectious Vaccines Sales, 2024-2029
5.3.3 By Application - Global Infectious Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Infectious Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Infectious Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Infectious Vaccines Revenue & Forecasts
6.2.1 By Region - Global Infectious Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Infectious Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Infectious Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Infectious Vaccines Sales & Forecasts
6.3.1 By Region - Global Infectious Vaccines Sales, 2018-2023
6.3.2 By Region - Global Infectious Vaccines Sales, 2024-2029
6.3.3 By Region - Global Infectious Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Infectious Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Infectious Vaccines Sales, 2018-2029
6.4.3 US Infectious Vaccines Market Size, 2018-2029
6.4.4 Canada Infectious Vaccines Market Size, 2018-2029
6.4.5 Mexico Infectious Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Infectious Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Infectious Vaccines Sales, 2018-2029
6.5.3 Germany Infectious Vaccines Market Size, 2018-2029
6.5.4 France Infectious Vaccines Market Size, 2018-2029
6.5.5 U.K. Infectious Vaccines Market Size, 2018-2029
6.5.6 Italy Infectious Vaccines Market Size, 2018-2029
6.5.7 Russia Infectious Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Infectious Vaccines Market Size, 2018-2029
6.5.9 Benelux Infectious Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Infectious Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Infectious Vaccines Sales, 2018-2029
6.6.3 China Infectious Vaccines Market Size, 2018-2029
6.6.4 Japan Infectious Vaccines Market Size, 2018-2029
6.6.5 South Korea Infectious Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Infectious Vaccines Market Size, 2018-2029
6.6.7 India Infectious Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Infectious Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Infectious Vaccines Sales, 2018-2029
6.7.3 Brazil Infectious Vaccines Market Size, 2018-2029
6.7.4 Argentina Infectious Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Infectious Vaccines Sales, 2018-2029
6.8.3 Turkey Infectious Vaccines Market Size, 2018-2029
6.8.4 Israel Infectious Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Infectious Vaccines Market Size, 2018-2029
6.8.6 UAE Infectious Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSL Limited (Australia)
7.1.1 CSL Limited (Australia) Company Summary
7.1.2 CSL Limited (Australia) Business Overview
7.1.3 CSL Limited (Australia) Infectious Vaccines Major Product Offerings
7.1.4 CSL Limited (Australia) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 CSL Limited (Australia) Key News & Latest Developments
7.2 Bavarian Nordic (Denmark)
7.2.1 Bavarian Nordic (Denmark) Company Summary
7.2.2 Bavarian Nordic (Denmark) Business Overview
7.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Major Product Offerings
7.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Bavarian Nordic (Denmark) Key News & Latest Developments
7.3 GlaxoSmithKline plc. (U.K.)
7.3.1 GlaxoSmithKline plc. (U.K.) Company Summary
7.3.2 GlaxoSmithKline plc. (U.K.) Business Overview
7.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Major Product Offerings
7.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline plc. (U.K.) Key News & Latest Developments
7.4 Emergent Bio Solutions Inc. (U.S.)
7.4.1 Emergent Bio Solutions Inc. (U.S.) Company Summary
7.4.2 Emergent Bio Solutions Inc. (U.S.) Business Overview
7.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Emergent Bio Solutions Inc. (U.S.) Key News & Latest Developments
7.5 MedImmune LLC (U.S.)
7.5.1 MedImmune LLC (U.S.) Company Summary
7.5.2 MedImmune LLC (U.S.) Business Overview
7.5.3 MedImmune LLC (U.S.) Infectious Vaccines Major Product Offerings
7.5.4 MedImmune LLC (U.S.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 MedImmune LLC (U.S.) Key News & Latest Developments
7.6 Johnson and Johnson (U.S.)
7.6.1 Johnson and Johnson (U.S.) Company Summary
7.6.2 Johnson and Johnson (U.S.) Business Overview
7.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Major Product Offerings
7.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Johnson and Johnson (U.S.) Key News & Latest Developments
7.7 Novartis AG (Switzerland)
7.7.1 Novartis AG (Switzerland) Company Summary
7.7.2 Novartis AG (Switzerland) Business Overview
7.7.3 Novartis AG (Switzerland) Infectious Vaccines Major Product Offerings
7.7.4 Novartis AG (Switzerland) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Novartis AG (Switzerland) Key News & Latest Developments
7.8 Merck and Company (U.S.)
7.8.1 Merck and Company (U.S.) Company Summary
7.8.2 Merck and Company (U.S.) Business Overview
7.8.3 Merck and Company (U.S.) Infectious Vaccines Major Product Offerings
7.8.4 Merck and Company (U.S.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Merck and Company (U.S.) Key News & Latest Developments
7.9 Sanofi Pasteur (France)
7.9.1 Sanofi Pasteur (France) Company Summary
7.9.2 Sanofi Pasteur (France) Business Overview
7.9.3 Sanofi Pasteur (France) Infectious Vaccines Major Product Offerings
7.9.4 Sanofi Pasteur (France) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Pasteur (France) Key News & Latest Developments
7.10 Pfizer Inc. (U.S.)
7.10.1 Pfizer Inc. (U.S.) Company Summary
7.10.2 Pfizer Inc. (U.S.) Business Overview
7.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Major Product Offerings
7.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Inc. (U.S.) Key News & Latest Developments
8 Global Infectious Vaccines Production Capacity, Analysis
8.1 Global Infectious Vaccines Production Capacity, 2018-2029
8.2 Infectious Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Infectious Vaccines Supply Chain Analysis
10.1 Infectious Vaccines Industry Value Chain
10.2 Infectious Vaccines Upstream Market
10.3 Infectious Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Infectious Vaccines in Global Market
Table 2. Top Infectious Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Infectious Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Infectious Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Infectious Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Infectious Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Infectious Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Infectious Vaccines Product Type
Table 9. List of Global Tier 1 Infectious Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Infectious Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Infectious Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Infectious Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Infectious Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Infectious Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Infectious Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Infectious Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Infectious Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Infectious Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Infectious Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Infectious Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Infectious Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Infectious Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Infectious Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Infectious Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Infectious Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Infectious Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Infectious Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Infectious Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Infectious Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Infectious Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Infectious Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Infectious Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Infectious Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Infectious Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Infectious Vaccines Sales, (K Units), 2024-2029
Table 46. CSL Limited (Australia) Company Summary
Table 47. CSL Limited (Australia) Infectious Vaccines Product Offerings
Table 48. CSL Limited (Australia) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. CSL Limited (Australia) Key News & Latest Developments
Table 50. Bavarian Nordic (Denmark) Company Summary
Table 51. Bavarian Nordic (Denmark) Infectious Vaccines Product Offerings
Table 52. Bavarian Nordic (Denmark) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Bavarian Nordic (Denmark) Key News & Latest Developments
Table 54. GlaxoSmithKline plc. (U.K.) Company Summary
Table 55. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Product Offerings
Table 56. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. GlaxoSmithKline plc. (U.K.) Key News & Latest Developments
Table 58. Emergent Bio Solutions Inc. (U.S.) Company Summary
Table 59. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Product Offerings
Table 60. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Emergent Bio Solutions Inc. (U.S.) Key News & Latest Developments
Table 62. MedImmune LLC (U.S.) Company Summary
Table 63. MedImmune LLC (U.S.) Infectious Vaccines Product Offerings
Table 64. MedImmune LLC (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. MedImmune LLC (U.S.) Key News & Latest Developments
Table 66. Johnson and Johnson (U.S.) Company Summary
Table 67. Johnson and Johnson (U.S.) Infectious Vaccines Product Offerings
Table 68. Johnson and Johnson (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson and Johnson (U.S.) Key News & Latest Developments
Table 70. Novartis AG (Switzerland) Company Summary
Table 71. Novartis AG (Switzerland) Infectious Vaccines Product Offerings
Table 72. Novartis AG (Switzerland) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Novartis AG (Switzerland) Key News & Latest Developments
Table 74. Merck and Company (U.S.) Company Summary
Table 75. Merck and Company (U.S.) Infectious Vaccines Product Offerings
Table 76. Merck and Company (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck and Company (U.S.) Key News & Latest Developments
Table 78. Sanofi Pasteur (France) Company Summary
Table 79. Sanofi Pasteur (France) Infectious Vaccines Product Offerings
Table 80. Sanofi Pasteur (France) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Sanofi Pasteur (France) Key News & Latest Developments
Table 82. Pfizer Inc. (U.S.) Company Summary
Table 83. Pfizer Inc. (U.S.) Infectious Vaccines Product Offerings
Table 84. Pfizer Inc. (U.S.) Infectious Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Inc. (U.S.) Key News & Latest Developments
Table 86. Infectious Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Infectious Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Infectious Vaccines Production by Region, 2018-2023 (K Units)
Table 89. Global Infectious Vaccines Production by Region, 2024-2029 (K Units)
Table 90. Infectious Vaccines Market Opportunities & Trends in Global Market
Table 91. Infectious Vaccines Market Drivers in Global Market
Table 92. Infectious Vaccines Market Restraints in Global Market
Table 93. Infectious Vaccines Raw Materials
Table 94. Infectious Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Infectious Vaccines Downstream
Table 96. Infectious Vaccines Downstream Clients in Global Market
Table 97. Infectious Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Infectious Vaccines Segment by Type in 2022
Figure 2. Infectious Vaccines Segment by Application in 2022
Figure 3. Global Infectious Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Infectious Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Infectious Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Infectious Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Vaccines Revenue in 2022
Figure 9. By Type - Global Infectious Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Infectious Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Infectious Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Infectious Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Infectious Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Infectious Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Infectious Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Infectious Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Infectious Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Infectious Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Infectious Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Infectious Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Infectious Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Infectious Vaccines Sales Market Share, 2018-2029
Figure 23. US Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Infectious Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Infectious Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Infectious Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Infectious Vaccines Sales Market Share, 2018-2029
Figure 37. China Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Infectious Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Infectious Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Infectious Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Infectious Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Infectious Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Infectious Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Infectious Vaccines by Region, 2022 VS 2029
Figure 54. Infectious Vaccines Industry Value Chain
Figure 55. Marketing Channels
